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Building research 
infrastructure across a health 
service
François Lamontagne and colleagues very 
usefully raise important questions about 
how health research in Canada might be 
better organized to enhance its impact on 
clinical practice.1 Given the achievements 
of health research in the United Kingdom 
during the coronavirus disease 2019 pan-
demic, the authors rightly laud the Clinical 
Research Network infrastructure for facili-
tating research that leads to key advances.
There are additional reasons for build-
ing research infrastructure widely across 
a health service. In England, National 
Health Service (NHS) hospitals in the can-
cer research network that participated in 
colorectal cancer trials had lower mortal-
ity rates from colorectal cancer than other 
hospitals, after adjusting for case mix and 
hospital-level variables. This trend was 
not restricted to academic centres or 
large hospitals, but there was a dose 
effect.2 The effect of research engagement 
on health care performance, though, is 
not unique to England or to research 
networks. A review of global literature on 
research engagement by health care pro-
viders found that North America pro-
vided the majority of studies reporting 
improved health care performance asso-
ciated with clinicians or health care org-
anizations that were active in research.3
That leads to the observation that per-
haps the most important aspect of Dame 
Sally Davies’ formation of the English 
National Institute for Health Research 
(NIHR) was not the adoption of any one 
specific element, but rather the creation 
of the overall system. This achievement 
was recognized in a recent review by the 
World Health Organization (WHO) that 
identified the NIHR as a world leader in 
implementing a comprehensive and 
coherent strategy to undertake the 
4 main research system functions of gov-
ernance, funding, building capacity and 
production and use of evidence.4
For example, building research net-
works across the NHS partly balanced the 
emphasis on funding a small number of 
Biomedical Research Centres (BRCs) to 
host leading medical academics who 
would spearhead research and transla-
tion. Many major scientific advances have 
come from BRCs. The University of 
Oxford’s BRC supports the RECOVERY 
trial, led by the university and involving 
investigators and clinical centres across 
the NIHR’s Clinical Research Network. 
BRCs helped the NIHR secure buy-in from 
leading medical academics, essential for 
the system to work in the context of some 
unease about focusing research agendas 
to meet NHS needs.
Lamontagne and colleagues identified 
challenges and progress in Canada, 
including clinical networks in Alberta. The 
WHO review provided more evidence of 
progress in Canada. First, the role of the 
Alberta networks in enhancing the trans-
lation and impact of research has been 
analyzed using the WHO’s systems 
approach.5 The WHO review also noted 
the pioneering comprehensive health 
research strategy developed in British 
Columbia through extensive stakeholder 
engagement, and the important role of 
McMaster University in evidence synthesis 
and translation (which has crucially con-
tinued during the pandemic).
Finally, it is worth recalling that a key 
influence behind the developments that 
led to the NIHR was the belief that clinical 
practice should be driven by evidence.
This belief, of course, goes back to 
McMaster and Dr. David Sackett (who 
then went to the University of Oxford).
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